Gestational alloimmune liver disease reconsidered: Advocating for a new nomenclature and enhanced diagnosis accuracy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-1)

Sum=12

Dec 9, 2025 (publication date) through Oct 31, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Pediatrics

ISSN

2219-2808

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Pediatr. Dec 9, 2025; 14(4): 106219
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.106219

Figure 1 T2 signal loss in liver (case 4).

Citation: Helali N, Gagnon H, Álvarez F. Gestational alloimmune liver disease reconsidered: Advocating for a new nomenclature and enhanced diagnosis accuracy. World J Clin Pediatr 2025; 14(4): 106219
URL: https://www.wjgnet.com/2219-2808/full/v14/i4/106219.htm
DOI: https://dx.doi.org/10.5409/wjcp.v14.i4.106219